GKOS Stock Analysis: Buy, Sell, or Hold?
GKOS - Glaukos Corporation
$184.89
0.00 (0.00%)
▲
5d:
+0.2%
30d:
+21.53%
90d:
+32.99%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When GKOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GKOS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GKOS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.67
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.97
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GKOS is currently trading at $184.89, which is considered extended relative to its 30-day fair value range of $154.74 to $182.45. From a valuation perspective, the stock is trading at a premium (Forward PE: 366.6) compared to its historical average (295.8). At these levels, the market is pricing in 7.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GKOS is in a strong uptrend. Immediate support is located at $175.04, while resistance sits at $191.62.
Market Sentiment: GKOS scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GKOS is in a strong uptrend. Immediate support is located at $175.04, while resistance sits at $191.62.
Market Sentiment: GKOS scores 19/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$154.74 -
$182.45
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
38.5%
Protect Your Profits
Holding GKOS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (19/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($197.15)
- NEUTRAL: PE elevated vs history but 7.4% growth expectation is conservative given 1896% recent growth
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$154.74 -
$182.45
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$10.07
(5.4%)
Support & Resistance Levels
Support Level
$175.04
Resistance Level
$191.62
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
366.63
Wall Street Target
$197.15
(+6.6%)
Revenue Growth (YoY)
49.5%
Earnings Growth (YoY)
1896.3%
Profit Margin
-30.7%
Valuation Premium vs History
+7.4% premium
PE vs Historical
366.6 vs 295.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+7.4%
(market-implied from PE analysis)
1-Year Target
$198.57
(+7%)
2-Year Target
$213.27
(+15%)
3-Year Target
$229.05
(+24%)
3-Yr Target (if PE normalizes)
(PE: 367→296)
PE COMPRESSION
$184.80
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 21, 2026 5:56 PM ET
Data refreshes hourly during market hours. Next update: 6:56 PM
Data refreshes hourly during market hours. Next update: 6:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GKOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Alex R Thurman
SELL
2511 shares
2026-03-25
Alex R Thurman
SELL
1521 shares
2026-03-24
Alex R Thurman
SELL
625 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
Advanced GKOS Option Strategies
Professional options setups generated by AI based on today's GKOS price and gamma walls.
